[Polypharmacological treatment of type 2 diabetes in daily clinical practice. A registry-based study in the county of Aarhus].
This study aims to describe the use and the level of HbA1c and furthermore, to describe the pharmacological treatment of type 2 diabetes in the County of Aarhus, Denmark. The County of Aarhus has a background population of 641,000 citizens. Data were collected from public data files for the period January 2000 to December 2000. Patients were classified as having type 2 diabetes if they were treated with diet alone, with antidiabetic tablets or, irrespective of treatment, if they were more than 40 years of age at time of diagnosis. In a population of 10,431 type 2 diabetics, 86% had a HbA1c measurement. Mean HbA1c was 7.48% (95% CI 7.45%-7.51%). A description of drug therapy showed that 66% had purchased a prescription for antidiabetic drugs, 63% for antihypertensive drugs and 14% for lipid-lowering drugs. 8% had purchased prescriptions for antidiabetics as well as antihypertensive and lipid-lowering drugs. In this study it was found that a large proportion of type 2 diabetics have a HbA1c measurement and several type 2 diabetics have a poor glycemic regulation. Few had purchased prescriptions for antidiabetics as well as antihypertensive and lipid-lowering drugs and most after a long duration of diabetes. It is concluded that there are possibilities for improving treatment of type 2 patients and that registers easily can be established to monitor the quality of diabetes treatment.